Trial
NCT02860130
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vantive Health LLC
Collaborators
Baxter Healthcare Corporation
Condition
Regional Citrate Anticoagulation (RCA)
Intervention
Prismocitrate 18
Why stopped
Study halted due to low recruitment, unrelated to safety or efficacy reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-22